# Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

> **NCT01554397** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 101 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **RADIATION:** PET-guided Bone Marrow-Sparing Intensity Modulated Radiation Therapy (IMRT)
- **DRUG:** Cisplatin
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT01554397
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-13
- **Primary completion:** 2021-06-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01554397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01554397, "Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01554397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*